Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06510816
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-15
Brief Title:
A Study Investigating the Efficacy and Safety of Intravitreal IVT Injections of ANX007 in Participants With Geographic Atrophy GA
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 3 Multicenter Randomized Parallel-Group Double-Masked 2-Arm Sham Controlled Study of the Efficacy Safety and Tolerability of ANX007 Administered by Intravitreal Injection in Patients With Geographic Atrophy GA Secondary to Age Related Macular Degeneration AMD
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARCHER II
Brief Summary:
The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-related macular degeneration AMD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None